Why Attend
The decisions shaping your pipeline, partnerships and growth strategy are on the agenda at Fierce JPM Week 2027.
Hear how biopharma leaders are approaching M&A, cross-border licensing, AI-driven decision-making and emerging therapies. Exchange perspectives with fellow executives and investors, meet potential partners and gain insights to inform your priorities for the year ahead.
Who You'll Meet
The Science, Deals and Strategies Shaping Biopharma’s Future
From replenishing pipelines to choosing where to invest, biopharma leaders face consequential decisions in 2027. Emerging therapies, cross-border licensing and evolving commercial models are creating new opportunities, while patent expirations and competition for promising assets are raising the stakes.
Fierce JPM Week 2027 brings together executives and investors to examine where the industry is committing capital and what it will take to deliver returns. Explore the next wave of M&A, AI’s role in portfolio decisions and the science moving toward commercialization. Gain perspective on how your peers are weighing risk, evaluating opportunities and positioning their businesses for growth